<DOC>
	<DOCNO>NCT00533858</DOCNO>
	<brief_summary>The aim study evaluate effect lacidipine losartan elderly hypertensive patient reduce 24 hour systolic BP variability , one potential parameter consider treat elderly hypertensive patient .</brief_summary>
	<brief_title>Effect Lacidipine Losartan 24 Hour Systolic Blood Pressure Variability Elderly Hypertensive Patients</brief_title>
	<detailed_description>In study , investigate effect two anti-hypertensive medication systolic BP variability profile pilot study . This prospective , randomize , open-label , blinded end point ( PROBE ) , parallel group study two treatment arm . At end initial 2-week washout period , eventual anti-hypertensive drug discontinue , patient fulfil inclusion criterion randomly treat lacidipine ( 4 mg ) losartan ( 50 mg ) , give daily hour morning ( approximately 8 AM ) 12 week . If BP goal ( SBP &lt; 140 mmHg DBP &lt; 90 mmHg ) attain 4 week 's treatment , 12.5 mg hydrochlorothiazide ( HCTS ) daily add . Patients check 24-h ambulatory BP monitoring ( ABPM ) end washout period 12 week active treatment . At visit , seat cuff SBP DBP , heart rate , use concomitant medication spontaneously report adverse event record .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Lacidipine</mesh_term>
	<criteria>Elderly patient ( age &gt; 65 year ) Essential hypertension ( systolic BP &gt; 140 mmHg diastolic BP &gt; 90 mm Hg ) Provide write informed content Secondary hypertension Myocardial infarction cerebrovascular accident within precede 6 month Clinically significant valvular heart disease , heart failure ( Class III , IV ) , renal insufficiency ( serum creatinine &gt; 2.5mg/dl ) , hepatic failure , uncontrolled diabetes mellitus Known hypersensitivity drug use study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Systolic hypertension</keyword>
</DOC>